NCT07042269

Brief Summary

The goal of this clinical trial is to determine the effects of a 12-week respiratory muscle training (RMT) intervention on cardiopulmonary function and compare its efficacy with aerobic exercise in older adults. The main questions it aims to answer are:

  • What are the effects of RMT compared to aerobic exercise on cardiopulmonary function?
  • What is the minimal effective duration (temporal threshold) for observable physiological adaptations to RMT?
  • To what extent are the training effects retained at 4-weeks post-intervention? Participants were randomly divided into RMT group and aerobic exercise group. The RMT group performed 12 weeks of progressive resistance training (initial, moderate, and high levels) using the Lung Fitness® breathing trainer, consisting of 10 breaths per set, 3 sets per session, twice daily (morning and evening), 5 days per week. The Aerobic Exercise group performed daily 10,000-step walking sessions 5 days per week, with exercise adherence assessed using the Exercise Adherence Questionnaire.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2021

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2022

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2023

Completed
2 years until next milestone

First Submitted

Initial submission to the registry

June 25, 2025

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 29, 2025

Completed
Last Updated

June 29, 2025

Status Verified

June 1, 2025

Enrollment Period

1.1 years

First QC Date

June 25, 2025

Last Update Submit

June 25, 2025

Conditions

Keywords

Aerobic ExerciseRespiratory Muscle TrainingCardiopulmonary FunctionOlder Adults

Outcome Measures

Primary Outcomes (1)

  • Inspiratory muscle function

    Inspiratory muscle function was quantified using a calibrated POWERbreathe K5 device (POWERbreathe International, Ltd., Southam, UK). Following standardized procedures \[18\], MIP and peak inspiratory flow (PIF) were recorded. Three technically acceptable maneuvers were performed at each session, with the highest value retained for analysis (coefficient of variation \<10%).

    Each subject was tested at five standardized time points (baseline, week 4, week 8, week 12 [post-intervention], and week 16 [post-detraining]).

Secondary Outcomes (1)

  • Pulmonary function

    Each subject was tested at five standardized time points (baseline, week 4, week 8, week 12 [post-intervention], and week 16 [post-detraining]).

Other Outcomes (1)

  • 6MWT

    Each subject was tested at five standardized time points (baseline, week 4, week 8, week 12 [post-intervention], and week 16 [post-detraining]).

Study Arms (2)

Aerobic Exercise Group

EXPERIMENTAL

* Performed daily 10,000-step walking (5 days/week) * Exercise adherence was assessed using the Exercise Adherence Questionnaire

Behavioral: Aerobic Exercise

Respiratory Muscle Training (RMT) Group

EXPERIMENTAL

* Performed 12-week progressive resistance training using the Lung Fitness breathing trainer (initial/moderate/high resistance levels) * Training protocol: 10 breaths/set, 3 sets/session (morning and evening), 5 days/week * Technique specification: 1. Diaphragmatic breathing pattern 2. Complete breath cycle = 1 repetition (inhalation ≤3s, exhalation ≤6s) * Resistance progression: * Initial level: Expiratory resistance - Level 1; Inspiratory resistance - Level 2 * Moderate level: Expiratory resistance - Level 2; Inspiratory resistance - Level 3 * High level: Expiratory resistance - Level 3; Inspiratory resistance - Level 4

Behavioral: Respiratory Muscle Training

Interventions

Performed daily 10,000-step walking (5 days/week)

Aerobic Exercise Group

Performed 12-week progressive resistance training using the Lung Fitness® breathing trainer (initial/moderate/high resistance levels)

Respiratory Muscle Training (RMT) Group

Eligibility Criteria

Age60 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Older adults aged 60-75 years; Regardless of sex; Individuals classified as either physically inactive or habitual exercisers;

You may not qualify if:

  • Individuals with cardiorespiratory diseases, hypertension, metabolic disorders, or other underlying medical conditions; Persons with impaired mobility, exercise contraindications, or inability to complete the exercise protocol; Inability to independently complete a Six-Minute Walk Test (6MWT) distance.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beijing Sports University

Beijing, Beijing Municipality, 100084, China

Location

Related Publications (1)

  • Rodrigues GD, Dal Lago P, da Silva Soares PP. Time-dependent effects of inspiratory muscle training and detraining on cardiac autonomic control in older women. Exp Gerontol. 2021 Jul 15;150:111357. doi: 10.1016/j.exger.2021.111357. Epub 2021 Apr 14.

    PMID: 33864832BACKGROUND

MeSH Terms

Interventions

ExerciseBreathing Exercises

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaMind-Body TherapiesComplementary TherapiesTherapeuticsExercise Movement TechniquesPhysical Therapy Modalities

Study Officials

  • Mei Xue Li, Doctor

    Beijing Sports University

    STUDY CHAIR
  • Xu Guo, Master

    Beijing Sports University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 25, 2025

First Posted

June 29, 2025

Study Start

June 1, 2021

Primary Completion

July 1, 2022

Study Completion

July 1, 2023

Last Updated

June 29, 2025

Record last verified: 2025-06

Locations